Clipping of news on Brazilian Culture, Law and Citizenship
 


Health

Red Stripe: Anvisa summons institutions to integrate workgroup

10/03/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.


 



ANVISA published until the second week of October, call notice to interested parties in joining the group will define the measures aimed to stimulate the rational use of medicines with red stripe. The decision was announced by the CEO of ANVISA, Dirceu Barbano, during the public hearing held on Thursday (27/9).

The group will work primarily in the formulation of communication actions directed at two audiences: healthcare professionals and consumers. The goal is to perform charitable campaigns that disseminate information about the dangers of indiscriminate use of medicines and warn about the importance of medical advice.

Medications red stripe correspond to 65% of the pharmaceutical market. For most products, the health legislation requires only the submission of a prescription upon purchase. In this category fall the anti-inflammatory indicated to immunological disorders, among others.

According Dirceu Barbano, the initial idea is not intensify inspection, but investing in public awareness. "The prescription is critical to ensure a correct diagnosis and the safe and effective use of the drug," he said.

The hearing on Thursday (27/9) gathered in the auditorium of ANVISA, in Brasilia, health professionals, pharmaceutical companies and representatives of civil society.



Source: ANVISA

Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.